Phospholipids
Group of substances
No structure available
Phospholipids is a group of substances, so there is no single molecule to show.
Background
Listing
- Schedules
- Schedule 1 to 4, conditions apply
- Exceptions reach
- Schedule 0
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
2 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Phospholipids Cancelled | Liposurf | Not stated | Cipla Medpro (Pty) Ltd | A400243 | S1 to S4conditions apply |
| Adenosine, nicotinic acid, phospholipids, vitamin b6 Cancelled | Lipostabil | Not stated | Rhone-poulenc Rorer SA (Pty) Ltd | H0656 | S1 to S4conditions apply |
2 more registered products name Phospholipids in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Phospholipids from soybeans | Essentiale | 300, 600 | Cfao Healthcare South Africa (Pty) Ltd | 2 registrations | |
| Phospholipids beractant | Survanta | 1 ml | Abbvie (Pty) Ltd | Z0211 | S4 |
Regulatory status
Where S1 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 1: sold by a pharmacist, no doctor's prescription needed. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S1 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Phospholipids
S4: Phospholipids
- when intended for parenteral administration.
Consolidated Schedules 06 July 2026, line 7554
S1: Phospholipids
- when applied for therapeutic purposes.
Consolidated Schedules 06 July 2026, line 1016
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.